Joseph L. Lasky - Concepedia

Author

Joseph L. Lasky

University of California, Los Angeles ORCID

Also Known As

D. D. Bigner, J. L. Lasky, J. Lasky, JOSEPH L. LASKY, Joseph L Lasky, Joseph L. Lasky, Joseph L. Lasky III, Joseph Lasky, Joseph Lasky III, Joseph Louis Lasky

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Harbor–UCLA Medical Center UCLA Medical Center The Lundquist Institute Emory University

About

Joseph L. Lasky is an author at University of California, Los Angeles specializing in medicine, neuro-oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	578
2	Health Sciences	1	1	19
3	Cell Biology	1	1	237
4	Immunology	1	1	67
5	Nephrology	1	1	19

Joseph L. Lasky

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
A Phase 3 Trial of <scp>l</scp> -Glutamine in Sickle Cell Disease Yutaka Niihara, Scott T. Miller, Julie Kanter, New England Journal of Medicine	2018	522
Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation Wei Guo, Joseph L. Lasky, Chun-Ju Chang, Nature Lineage PlasticityMedicineMixed-phenotype Acute LeukemiaMulti-genetic EventsStem Cell Research	2008	237
In search of druggable targets for GBM amino acid metabolism Eduard H. Panosyan, Henry J. Lin, Jan Köster, BMC Cancer	2017	131
Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial Rajkumar Venkatramani, Lingyun Ji, Joseph L. Lasky, Journal of Neuro-Oncology MedicineYoung ChildrenPediatricsPediatric Hematology	2013	75
Asparagine Depletion Potentiates the Cytotoxic Effect of Chemotherapy against Brain Tumors Eduard H. Panosyan, Yuntao Wang, Peng Xia, Molecular Cancer Research	2014	69
Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Joseph L. Lasky, Eduard H. Panosyan, Ashley Plant, PubMed Pediatric Brain TumorsImmunologyImmunoeditingImmunotherapeuticsHigh-grade Gliomas	2013	67
Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease James F. Casella, Bruce Barton, Julie Kanter, JAMA	2021	41
Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids Eduard H. Panosyan, Joseph L. Lasky, Henry J. Lin, Journal of Neuro-Oncology Neuro-oncologyAmino AcidsMedicineClinical AggressivenessCatabolism	2016	37
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial Margaret V. Ragni, Scott D. Rothenberger, Robert Feldman, The Lancet Haematology ThrombosisHematologyGynecologyHemostasisCoagulopathy	2023	34
Congenital Brain Tumors Joseph L. Lasky, Eun Jun Choi, Samantha H. Johnston, Journal of Pediatric Hematology/Oncology Developmental AnomalyNeuro-oncologyRadiation OncologyPediatric Brain TumorsAstrocytic Lineage	2008	28

Page 1